CLINICAL IMMUNOLOGY
No evidence of West Nile virus infection among Polish patients with encephalitis
More details
Hide details
Submission date: 2016-09-16
Acceptance date: 2016-10-26
Publication date: 2017-01-24
Cent Eur J Immunol 2016;41(4):383-385
KEYWORDS
ABSTRACT
West Nile virus (WNV) infection usually causes mild febrile illness, but in a small proportion of patients it can lead to encephalitis. Epidemiological studies of WNV indicate fast spread of infection worldwide and in Europe, but there have been no comprehensive studies of WNV infection among encephalitis patients in Poland.
Here we present the results of WNV RNA and anti-WNV testing in serum and cerebrospinal fluid (CSF) samples in 80 patients with the clinical diagnosis of viral encephalitis. WNV RNA was not detected in any of the analyzed samples. Anti-WNV IgG and IgM were not present in CSF in any of the investigated patients, but anti-WNV IgM were unexpectedly detected in serum of 14 subjects. The latter represented false positive results are probably related to cross reactivity of antibodies.
Although there was no evidence of WNV infection in any of our patients, epidemiological situation in the neighbouring countries warrants vigilance and appropriate measures, including introduction of specific diagnostic tools into clinical practice, seem necessary.
REFERENCES (29)
1.
Chancey C, Grinev A, Volkova E, et al. (2015): The global ecology and epidemiology of West Nile virus. Biomed Res Int 2015: 376230.
2.
Sejvar JJ (2014): Clinical manifestations and outcomes of West Nile virus infection. Viruses 6: 606-623.
3.
Bode AV, Sejvar JJ, Pape WJ, et al. (2006): West Nile virus disease: a descriptive study of 228 patients hospitalized in a 4-county region of Colorado in 2003. Clin Infect Dis 42: 1234-1240.
4.
Carson PJ, Borchardt SM, Custer B, et al. (2012): Neuroinvasive disease and West Nile virus infection, North Dakota, USA, 1999-2008. Emerg Infect Dis 18: 684-686.
5.
Nash D, Mostashari F, Fine A, et al. (2001): The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 344: 1807-1814.
6.
Patnaik JL, Harmon H, Vogt RL (2006): Follow-up of 2003 human West Nile virus infections, Denver, Colorado. Emerg Infect Dis 12: 1129-1131.
7.
Kopel E, Amitai Z, Bin H, et al. (2011): Surveillance of West Nile virus disease, Tel Aviv district, Israel, 2005 to 2010. Euro Surveill 16.
8.
Pepperell C, Rau N, Krajden S, et al. (2003): West Nile virus infection in 2002: morbidity and mortality among patients admitted to hospital in southcentral Ontario. CMAJ 168: 1399-1405.
9.
Tsai TF, Popovici F, Cernescu C, et al. (1998): West Nile encephalitis epidemic in southeastern Romania. Lancet 352: 767-771.
10.
Platonov AE, Shipulin GA, Shipulina OY, et al. (2001): Outbreak of West Nile virus infection, Volgograd Region, Russia, 1999. Emerg Infect Dis 7: 128-132.
11.
Weinberger M, Pitlik SD, Gandacu D, et al. (2001): West Nile fever outbreak, Israel, 2000: epidemiologic aspects. Emerg Infect Dis 7: 686-691.
12.
Lanciotti RS, Ebel GD, Deubel V, et al. (2002): Complete genome sequences and phylogenetic analysis of West Nile virus strains isolated from the United States, Europe, and the Middle East. Virology 298: 96-105.
13.
May FJ, Davis CT, Tesh RB, et al. (2001): Phylogeography of West Nile virus: from the cradle of evolution in Africa to Eurasia, Australia, and the Americas. J Virol 85: 2964-2974.
14.
Davis LE, DeBiasi R, Goade DE, et al. (2006): West Nile virus neuroinvasive disease. Ann Neurol 60: 286-300.
15.
Petersen LR, Marfin AA. (2002): West Nile virus: a primer for the clinician. Ann Intern Med 137: 173-179.
16.
Sejvar JJ, Haddad MB, Tierney BC, et al. (2003): Neurologic manifestations and outcome of West Nile virus infection. JAMA 290: 511-515.
17.
Ahmed S, Libman R, Wesson K, et al. (2000): Guillain-Barre syndrome: An unusual presentation of West Nile virus infection. Neurology 55: 144-146.
18.
Almhanna K, Palanichamy N, Sharma M, et al. (2003): Unilateral brachial plexopathy associated with West Nile virus meningoencephalitis. Clin Infect Dis 36: 1629-1630.
19.
Loeb M, Hanna S, Nicolle L, et al. (2008): Prognosis after West Nile virus infection. Ann Intern Med 149: 232-241.
20.
Murray K, Walker C, Herrington E, et al. (2010): Persistent infection with West Nile virus years after initial infection. J Infect Dis 201: 2-4.
21.
Czupryna P, Niczyporuk J, Samorek-Salamonowicz E, et al. (2014): Detection of West Nile Virus RNA in patients with meningitis in Podlaskie Province. Przegl Epidemiol 68: 17-20, 109-111.
22.
Kondrusik M, Ferenczi E, Zajkowska J, et al. (2007): [The evaluation of serum presence of antibodies reacting with West Nile Fever virus (WNV) antigens among inhabitants from Podlaskie and Swietokrzyskie region]. Przegl Epidemiol 61: 409-416.
23.
Amicizia D, Domnich A, Panatto D, et al. (2013): Epidemiology of tick-borne encephalitis (TBE) in Europe and its prevention by available vaccines. Hum Vaccin Immunother 9: 1163-1171.
24.
Hermanowska-Szpakowicz T, Grygorczuk S, Kondrusik M, et al. (2006): Infections caused by West Nile virus. Przegl Epidemiol 60: 93-98.
25.
Kubica-Biernat B, Kruminis-Lozowska W, Stanczak J, et al. (2009): A study on the occurrence of West Nile virus in mosquitoes (Diptera: Culicidae) on the selected areas in Poland. Wiad Parazytol 55: 259-263.
26.
Niczyporuk JS, Samorek-Salamonowicz E, Lecollinet S, et al.(2015): Occurrence of West Nile virus antibodies in wild birds, horses, and humans in Poland. Biomed Res Int 2015: 234181.
27.
Niczyporuk JS, Samorek-Salamonowicz E, Mizak WK(2011): The survey of wild birds for West Nile virus in Poland. Pol J Vet Sci 14: 573-577.
28.
Sambri V, Capobianchi MR, Cavrini F, et al. (2013): Diagnosis of west nile virus human infections: overview and proposal of diagnostic protocols considering the results of external quality assessment studies. Viruses. 5: 2329-2348.
29.
Zou S, Foster GA, Dodd RY, et al. (2010): West Nile fever characteristics among viremic persons identified through blood donor screening. J Infect Dis 202: 1354-1361.